Home Infusion Therapy Market

Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors), and By Application (Total Parenteral Nutrition, Anti-infective Therapy, Enteral Nutrition, Hydration Therapy, Chemotherapy, IVIg/Specialty Pharmaceuticals, and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13716
  • Published Date: Sep, 2023
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global home infusion therapy market was valued at USD 35.0 billion in 2022, growing at a CAGR of 8.5% from 2023 to 2032. The market is expected to reach USD 79.1 billion by 2032. Chronic diseases such as cancer, autoimmune disorders, and infectious diseases necessitate long-term drug treatment, frequently delivered via home infusion therapy. The rising prevalence of these disorders is increasing the demand for home infusion therapy. Home infusion therapy is becoming more accessible and efficient for patients and healthcare providers as technology advances, such as the creation of portable infusion pumps and electronic health records.

Market Introduction:

Home infusion therapy is a specialized medical treatment that involves administering medication, such as antivirals or immunological globin, fluids, or nutrients intravenously to patients in their homes using various equipment such as pumps, catheters, and vials. It is advised for individuals who require long-term or frequent infusion therapy due to infections, malignancies, or chronic illnesses such as multiple sclerosis (MS) or rheumatoid arthritis. Home infusion therapy provides comfort and convenience while improving quality of life and lowering the risk of hospital-acquired infections. Furthermore, it allows patients to preserve their independence and control over their treatment while obtaining essential medical care. Home infusion therapy is extremely effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies, mostly used to treat diabetes and other gastrointestinal and oncological problems.

Home Infusion Therapy Market Size

Get an overview of this study by requesting a free sample

Recent Development

In June 2021, The United States Food and Drug Administration (FDA) granted Aducanumab (Aduhelm) expedited approval as a therapy for Alzheimer's disease. This is the first infusion therapy approved by the FDA to address the underlying biology of Alzheimer's disease.

In January 2021, Amedisys partnered with Option Care Health to provide COVID-19 infusion therapy to the Vulnerable population.

In June 2023, Baxter International, an American healthcare business, will introduce the Progressa+ Next Gen ICU bed to fulfil patients' essential needs at home. This technology makes it easy for nurses to care for patients while assisting with home rehabilitation.

In May 2023, Fresenius Kabi, a global healthcare firm, began negotiations with Premier, Inc., an American healthcare corporation, resulting in pricing and term benefits for the Ivenix Infusion System. This technology is intended to improve infusion pumps' dependability and ease of use.

In May 2023, Option Care Health, a healthcare service provider, and Amedisys Inc., a renowned provider of home health services, will launch an independent platform for home care services.

Market Dynamics:

Drivers

Rising Prevalence of Chronic Diseases- One of the primary factors driving market expansion is the increase in the number of people suffering from chronic diseases such as cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes. Concurrently, the growing geriatric population, susceptible to life-threatening disorders and requiring regular medical attention, such as infusion therapy, is positively boosting market growth. Furthermore, the introduction of various government programmes, favourable reimbursement policies, and the rising expenses of extended hospital stays are driving patients to choose home infusion therapy, fueling market expansion. Aside from that, the shifting demand for home healthcare services due to their convenience and cost-effectiveness, as well as the expanding requirement for hospital space and beds, are driving market growth.

Restraints:

Medical Overdose- Medication overdosage may result in hazardous situations, a shortage of qualified nurses in developing and underdeveloped regions, irregularities in the operation of infusion devices, and incorrect usage of infusion devices, all of which may impede the growth of this market.

Opportunities:

Increase Prevalence of Hospital-Acquired Infections- The increased prevalence of hospital-acquired infections (HAIs) due to prolonged exposure to contaminated equipment, bed linens, and air droplets is boosting market growth. Furthermore, creative technical breakthroughs, such as creating lightweight, portable, and simple-to-use infusion pumps outfitted with advanced drip systems for precise and real-time monitoring of IV treatments, are creating lucrative opportunities for the market.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global home infusion therapy market, with a 55% market revenue share in 2022.

North America is a prominent home infusion therapy market region, owing to rising chronic disease incidence, treatment costs, technical advances, and product launches, which are projected to drive regional expansion. According to the Canadian Cancer Society, an estimated 225,800 new cancer cases will be diagnosed in 2020, with an expected 83,300 cancer fatalities in Canada.

Furthermore, according to American Cancer Society statistics from 2021, around 1.8 million new cancer cases were recorded in the United States alone in 2020. The most common cancers in the United States include breast, lung, prostate, colorectal, bladder, and skin cancers. Furthermore, due to lower costs and increased patient mobility, there is a rising shift from acute care to home care settings, expected to drive further growth. Improvements in the healthcare business and the usage of increasingly sophisticated medical equipment are also driving up demand for regional goods.

North America Region Home Infusion Therapy Market Share in 2022 - 55%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product Segment Analysis

The product segment is divided into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The infusion pumps segment dominated the market, with a market share of around 40% in 2022. Infusion pumps control the delivery of fluids, drugs, or nutrients into a patient's bloodstream. Intravenous sets are sterile devices that connect an infusion pump to a vein in the patient. IV cannulas are thin tubes placed into a vein to allow medication or fluids to be administered. Needleless connectors attach IV tubing to IV cannulas without needing a needle. These devices are critical for safe and successful home infusion therapy and drive market expansion.

Application Segment Analysis

The application segment is divided into total parenteral nutrition, anti-infective therapy, enteral nutrition, hydration therapy, chemotherapy, IVIg/specialty pharmaceuticals, and others. The anti-infective therapy segment dominated the market, with a market share of around 34% in 2022. The anti-infective therapy segment will likely dominate the global home infusion therapy market throughout the forecast period. One of the most commonly prescribed home infusion therapies is anti-infective therapy. However, minimal hazards in such therapy can be mitigated by a team approach combined with appropriate patient selection criteria, an organized follow-up process, and a focus on patient education. Rising awareness initiatives by various government and non-profit organizations, rising prevalence of infectious diseases, rising financing, and rising research and development activities are the primary drivers driving the growth of the infectious disease drugs market.

Some of the Key Market Players:
  • CVS/Coram
  • Option Care Health
  • BriovaRx/Diplomat (UnitedHealth Optum)
  • PharMerica
  • Fresenius Kabi
  • ICU Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smiths Medical
  • Terumo Corporation
  • JMS Co. Ltd.

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 35.0  Billion
Market size value in 2032 USD 79.1 Billion
CAGR (2023 to 2032) 8.5%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product, Application

Frequesntly Asked Questions

As per The Brainy Insights, the size of the home infusion therapy market was valued at USD 35.0 billion in 2022 to USD 79.1 billion by 2032.

The global home infusion therapy market is growing at a CAGR of 8.5% during the forecast period 2023-2032.

North America emerged as the largest home infusion therapy market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product
          4.3.2. Market Attractiveness Analysis by Application
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rising prevalence of chronic diseases
    5.3. Restraints
          5.3.1. Medical overdose
    5.4. Opportunities
          5.4.1. Increase prevalence of hospital-acquired infections
    5.5. Challenges
          5.5.1. High cost

6. Global Home Infusion Therapy Market Analysis and Forecast, By Product
    6.1. Segment Overview
    6.2. Infusion Pumps
    6.3. Intravenous Sets
    6.4. IV Cannulas
    6.5. Needleless Connectors

7. Global Home Infusion Therapy Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Total Parenteral Nutrition
    7.3. Anti-infective Therapy
    7.4. Enteral Nutrition
    7.5. Hydration Therapy
    7.6. Chemotherapy
    7.7. IVIg/Specialty Pharmaceuticals
    7.8. Others

8. Global Home Infusion Therapy Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Home Infusion Therapy Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Home Infusion Therapy Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. CVS/Coram
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Option Care Health
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. BriovaRx/Diplomat (UnitedHealth Optum)
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. PharMerica
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Fresenius Kabi
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. ICU Medical, Inc.
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. B. Braun Melsungen AG
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Baxter
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. BD
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Caesarea Medical Electronics
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Smiths Medical
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. Terumo Corporation
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
    10.13. JMS Co. Ltd.
          10.13.1. Business Overview
          10.13.2. Company Snapshot
          10.13.3. Company Market Share Analysis
          10.13.4. Company Product Portfolio
          10.13.5. Recent Developments
          10.13.6. SWOT Analysis

List of Table

1. Global Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

2. Global Infusion Pumps, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion) 

3. Global Intravenous Sets, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion) 

4. Global IV Cannulas, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion) 

5. Global Needleless Connectors, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

6. Global Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

7. Global Total Parenteral Nutrition, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

8. Global Anti-infective Therapy, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

9. Global Enteral Nutrition, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

10. Global Hydration Therapy, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

11. Global Chemotherapy, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

12. Global IVIg/Specialty Pharmaceuticals, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

13. Global Others, Home Infusion Therapy Market, By Region, 2019-2032 (USD Billion)

14. North America Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

15. North America Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

16. U.S. Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

17. U.S. Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

18. Canada Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

19. Canada Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

20. Mexico Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

21. Mexico Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

22. Europe Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

23. Europe Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

24. Germany Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

25. Germany Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

26. France Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

27. France Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

28. U.K. Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

29. U.K. Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

30. Italy Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

31. Italy Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

32. Spain Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

33. Spain Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

34. Asia Pacific Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

35. Asia Pacific Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

36. Japan Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

37. Japan Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

38. China Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

39. China Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

40. India Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

41. India Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

42. South America Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

43. South America Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

44. Brazil Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

45. Brazil Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

46. Middle East and Africa Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

47. Middle East and Africa Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

48. UAE Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

49. UAE Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

50. South Africa Home Infusion Therapy Market, By Product, 2019-2032 (USD Billion)

51. South Africa Home Infusion Therapy Market, By Application, 2019-2032 (USD Billion)

List of Figures 

1. Global Home Infusion Therapy Market Segmentation

2. Global Home Infusion Therapy Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Home Infusion Therapy Market Attractiveness Analysis by Product

9. Global Home Infusion Therapy Market Attractiveness Analysis by Application

10. Global Home Infusion Therapy Market Attractiveness Analysis by Region

11. Global Home Infusion Therapy Market: Dynamics

12. Global Home Infusion Therapy Market Share by Product (2023 & 2032)

13. Global Home Infusion Therapy Market Share by Application (2023 & 2032)

14. Global Home Infusion Therapy Market Share by Regions (2023 & 2032)

15. Global Home Infusion Therapy Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global home infusion therapy market based on the below-mentioned segments:

Global Home Infusion Therapy Market By Product:

  • Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Global Home Infusion Therapy Market By Application:

  • Total Parenteral Nutrition
  • Anti-infective Therapy
  • Enteral Nutrition
  • Hydration Therapy
  • Chemotherapy
  • IVIg/Specialty Pharmaceuticals
  • Others

Global Home Infusion Therapy Market By Region:                   

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date